Enzymatic Alter-Egos Unmasked

Some proteins lead double or even quadruple lives. In 1994, researchers discovered the gene responsible for Wiskott Aldrich syndrome, an X-linked genetic disorder in which affected patients generally succumb to infections or cancer. Because of the observed immune dysfunction, the protein, called WASP, was believed to regulate lymphocytes or platelets.1 But, challenging the traditionally held one-protein-one-function notion, subsequent studies found that WASP had several jobs, among them orga

Written byJack Lucentini
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Some proteins lead double or even quadruple lives. In 1994, researchers discovered the gene responsible for Wiskott Aldrich syndrome, an X-linked genetic disorder in which affected patients generally succumb to infections or cancer. Because of the observed immune dysfunction, the protein, called WASP, was believed to regulate lymphocytes or platelets.1

But, challenging the traditionally held one-protein-one-function notion, subsequent studies found that WASP had several jobs, among them organizing cellular actin skeletons and communicating between the immune system's T and B cells.2 This multifunctionality, considered an oddity a decade ago,3 might explain the disorder's wide array of manifestations. It turns out, however, that WASP's multitasking is not an anomaly at all. Multifunctional or "moonlighting" proteins have turned out to be surprisingly common, and examples of proteins with as many as five proposed functions have emerged.4

"People had had a notion for many, many years that some proteins had more than one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies